Full-Time

Neuroscience Heath and Science Professional

Posted on 5/2/2025

Deadline 5/17/25
Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

Compensation Overview

$71.7k - $180.2k/yr

+ Quarterly Sales Incentive Bonus

Junior, Mid

No H1B Sponsorship

Montgomery, IL, USA

Candidates must live within 25 miles of the border of the territory.

Category
Sales Development Representative
Inside Sales
Sales & Account Management
Required Skills
Sales
Marketing
Customer Service
Data Analysis
Requirements
  • Bachelor’s Degree
  • Minimum 2 years of experience in one or more of the following; OR an associate’s degree with 6+ years of experience; OR high school diploma (or equivalent) with 8+ years of relevant experience: Professional Sales or Promotional Activity, Small Business Owner or other Entrepreneurial experience, Marketing, Customer Service and/or Account Management, Relevant Healthcare/Scientific roles (e.g., RN, Pharmacist, PT, OT, etc.), Educator (e.g., Teacher, Principal), Full Time Military experience
  • Must live within 25 miles of the border of the territory.
  • Valid US driver’s license and a driving record in compliance with company standards.
  • Ability to travel to all accounts/office locations within territory
  • Depending on size of territory and business need, candidates may be required to stay overnight as necessary.
Responsibilities
  • Drives sales in assigned territory
  • Engages with customers both face to face and virtually
  • Develops and implements effective business and territory call plans; effectively identifies and implements live/virtual engagement strategies with customer to maximize overall effectiveness and impact
  • Effectively builds rapport and relationships with customers in both live and virtual environments; uses judgment to maintain customer engagement by successfully utilizing existing and ever-changing digital tools effectively for successful customer engagement
  • Understands and leverages internal reports and analytics to assist with identifying, developing, and implementing strategic business opportunities
  • Compliantly leverages product and disease state knowledge to appropriately educate providers on unbranded and branded product value proposition for relevant patient populations and effectively and strategically utilizes approved clinically oriented disease state information and patient resources, as applicable
  • Demonstrates strong teamwork capabilities to collaborate effectively and compliantly across the organization to address customer inquiries and advance Pfizer objectives.
  • Completes all administrative expectations on time and compliantly.
Desired Qualifications
  • 1 year of pharmaceutical, biotech, medical sales and/or medical related marketing.
  • Strong track record of sales or marketing success, strong territory management skills, outstanding communications skills, as well as demonstrated teamwork, leadership ability and accountability.
  • Experience with applicable disease states, therapeutic area, and products.
  • Knowledge of posted territory customers and markets (prescribers/HCPs/institutions/organizations).
  • Reside within the territory boundaries.

Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's operations is its partnership with BioNTech to develop a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also initiatives to ensure that vaccines reach underserved populations. The company's goal is to continuously expand its range of healthcare solutions while maintaining a commitment to improving public health.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Activist investor Starboard Value's $1B stake may drive strategic changes and increase value.
  • Pfizer's investment in Enara Bio strengthens its position in the immunotherapy market.
  • Backing Promise Bio aligns with Pfizer's strategy to enhance its precision medicine portfolio.

What critics are saying

  • Emerging biotech companies like Trimtech and Normunity could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses potential revenue challenges for Pfizer.
  • Activist investor involvement may pressure Pfizer to alter business strategies.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing R&D capabilities and drug discovery.
  • Pfizer's focus on precision medicine diversifies its therapeutic areas and strengthens its portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

Benzinga
Oct 3rd, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is

INACTIVE